Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I ADME Study of [14C]KDT-3594 in Healthy Adult Male Subjects
jRCT2071220057Phase 1Completed
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of matsupexole, sponsored by Kissei Pharmaceutical Co., Ltd. Primary endpoints: Urinary and fecal radioactivity excretion and excretion rate, Cumulative excretion and cumulative excretion rate and 2 more. Started Nov 2022; status: completed.
02
Drugs
matsupexole
Beyond the preview
Go deeper on jRCT2071220057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071220057.